Ensysce Biosciences is a clinical-stage company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin-Activated Abuse Protection (TAAP™) and Multi-Pill ...
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update Financial and business highlights Total H1 2024 incomes of €82.5 million thanks to Company's new partnerships.Ne ...
Nepra Foods (NPRFF) has secured $1M in inventory/purchase order financing and $1.75M in accounts receivable financing from Gateway Trade Funding. The financing allows 90% of ...